The global market for Thiamine was estimated at US$245.1 Million in 2024 and is projected to reach US$487.6 Million by 2030, growing at a CAGR of 12.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Thiamine market.
Thiamine Market Trends & Drivers Summarized
How Is the Thiamine Market Expanding in Nutrition and Pharmaceutical Applications?
Thiamine (Vitamin B1) plays a crucial role in human metabolism, nerve function, and energy production, making it a vital ingredient in dietary supplements, fortified foods, and pharmaceutical formulations. The rising prevalence of vitamin deficiencies, increasing awareness of preventive healthcare, and the expansion of functional foods are driving the demand for thiamine-enriched products. Additionally, thiamine's application in treating neurological disorders, beriberi, and Wernicke-Korsakoff syndrome is further expanding its pharmaceutical use. However, supply chain disruptions, fluctuating raw material costs, and stringent regulatory standards pose challenges for market growth. As consumer demand for personalized nutrition increases, how will thiamine supplementation evolve to meet diverse dietary needs?What Technological Innovations Are Advancing Thiamine Production?
Advancements in biotechnology are improving thiamine synthesis and bioavailability. Encapsulation technologies are enhancing nutrient stability, ensuring prolonged shelf life in functional foods and supplements. AI-driven nutrient profiling is enabling personalized supplementation, optimizing thiamine intake based on individual metabolic needs. Additionally, sustainable fermentation processes are reducing production costs and environmental impact, supporting large-scale thiamine manufacturing.Why Is the Demand for Thiamine Increasing?
The growing prevalence of vitamin deficiencies, rising interest in energy-boosting supplements, and increasing consumption of fortified foods are driving demand for thiamine. The aging population and increasing awareness of cognitive health are further fueling its adoption in neuroprotective formulations. Additionally, the expansion of vegan and plant-based diets is contributing to thiamine fortification in alternative food products.What Factors Are Driving the Growth of the Thiamine Market?
The market is expanding due to advancements in vitamin formulation technologies, increasing investments in nutritional research, growing demand for functional foods, and rising consumer preference for preventive healthcare. As personalized nutrition gains traction, thiamine supplementation is expected to play a key role in supporting metabolic and neurological health.Scope of Study:
The report analyzes the Thiamine market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: End-Use (Food & Beverages, Animal Feed, Pharmaceuticals, Dietary Supplements, Others)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Food & Beverages segment, which is expected to reach US$156.5 Million by 2030 with a CAGR of a 10.8%. The Animal Feed segment is also set to grow at 10.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $66.8 Million in 2024, and China, forecasted to grow at an impressive 16.1% CAGR to reach $100.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Thiamine Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Thiamine Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Thiamine Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as BASF SE, Brother Enterprises Holding Co., Ltd., Chemizo Enterprise, DSM Nutritional Products, HPC Standards GmbH and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 36 companies featured in this Thiamine market report include:
- BASF SE
- Brother Enterprises Holding Co., Ltd.
- Chemizo Enterprise
- DSM Nutritional Products
- HPC Standards GmbH
- Huazhong Pharmaceutical Co., Ltd.
- Jiangsu Jubang Pharmaceutical Co., Ltd.
- Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Koninklijke DSM N.V.
- Lonza Group AG
- McCartan`s Pharmacy
- Molekula Group
- Nutricost
- PharmoVit
- Prinova Group LLC
- Rochem International Inc.
- Zhejiang Tianxin Pharmaceutical Co., Ltd.
- Spectrum Chemical Manufacturing Corp.
- Supreem Pharmaceuticals Mysore Pvt. Ltd.
- TCI Chemicals (India) Pvt. Ltd.
- Wörwag Pharma GmbH & Co. KG
- Xinfa Pharmaceutical Co., Ltd.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BASF SE
- Brother Enterprises Holding Co., Ltd.
- Chemizo Enterprise
- DSM Nutritional Products
- HPC Standards GmbH
- Huazhong Pharmaceutical Co., Ltd.
- Jiangsu Jubang Pharmaceutical Co., Ltd.
- Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Koninklijke DSM N.V.
- Lonza Group AG
- McCartan`s Pharmacy
- Molekula Group
- Nutricost
- PharmoVit
- Prinova Group LLC
- Rochem International Inc.
- Zhejiang Tianxin Pharmaceutical Co., Ltd.
- Spectrum Chemical Manufacturing Corp.
- Supreem Pharmaceuticals Mysore Pvt. Ltd.
- TCI Chemicals (India) Pvt. Ltd.
- Wörwag Pharma GmbH & Co. KG
- Xinfa Pharmaceutical Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 183 |
Published | August 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 245.1 Million |
Forecasted Market Value ( USD | $ 487.6 Million |
Compound Annual Growth Rate | 12.1% |
Regions Covered | Global |